Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways

Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical biology 2020-01, Vol.58 (1), p.828-837
Hauptverfasser: Wang, Zhaohui, Chen, Zhi, Li, Bingsheng, Zhang, Bo, Du, Yongchao, Liu, Yuhang, He, Yao, Chen, Xiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 837
container_issue 1
container_start_page 828
container_title Pharmaceutical biology
container_volume 58
creator Wang, Zhaohui
Chen, Zhi
Li, Bingsheng
Zhang, Bo
Du, Yongchao
Liu, Yuhang
He, Yao
Chen, Xiang
description Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation. In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells. Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.
doi_str_mv 10.1080/13880209.2020.1809462
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7470153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_dc779ebd2b9e4db4bfde2914d79c9348</doaj_id><sourcerecordid>2509433348</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</originalsourceid><addsrcrecordid>eNp9ks1u1DAUhSMEomXgEZAssWGT1o6dvw2iHVEYdQQIlbVlx9cTjxI72E6rvBpLnoBHwsMUpLJg499zPl_5nix7SfAZwQ0-J7RpcIHbsyKNZ6TBLauKR9kpqRnLS0Kqx2mdNPlBdJI9C2GPMS4pLZ9mJ7RoqgqX7Wn2Yz37bh6NRSJGsLOIEJAHKwZkbAQfookmbbSR3gUTkNPIyRD93EVzC8jC1Hs3idgvSC4ozNPkIQRjdwgmE3sYkjsfIYDt-mVMpOiFDQnqLIrJOu_69FJv5PEo4ZMJ3Wy_sPOPV_nP75dIWIU-b-j1-cX1DQpml2obDvzDo3diCc-zJ1oMAV7cz6vs69W7m_WHfPvp_WZ9sc07VrIibxtBtSBEU0JZoXSpasIAU1WLThRE1g2VFSaN0sCwbMoKtNQVlqIsqroVDV1lmyNXObHnkzej8At3wvDfB87vuPDRdANw1dV1C1IVsgWmJJNaQdESpuq2ayk7sN4cWdMsR1Ad2PQtwwPowxtrer5zt7xmNSapi6vs9T3Au28zhMhHEzoYBmHBzYEXjLYVLWtSJOmrf6R7N_v0i0lVpthQeqyoPKq61OfgQf8thmB-SBz_kzh-SBy_T1zyvT36jNXOj-LO-UHxKJbBeZ1a3ZnA6f8RvwCCo-Hq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2509433348</pqid></control><display><type>article</type><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><source>Taylor &amp; Francis Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</creator><creatorcontrib>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</creatorcontrib><description>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation. In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells. Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</description><identifier>ISSN: 1388-0209</identifier><identifier>EISSN: 1744-5116</identifier><identifier>DOI: 10.1080/13880209.2020.1809462</identifier><identifier>PMID: 32866059</identifier><language>eng</language><publisher>Abingdon: Taylor &amp; Francis</publisher><subject>1-Phosphatidylinositol 3-kinase ; Actin ; AKT protein ; Colorimetry ; Creatinine ; Curcumin ; Enzyme-linked immunosorbent assay ; Fibrosis ; Immunohistochemistry ; Inflammation ; Interleukin 6 ; Lipopolysaccharides ; Mesenchyme ; Nephropathy ; NF-κB protein ; Renal function ; Signal transduction ; Smooth muscle ; TLR4 protein ; Toll-like receptors ; transforming growth factor beta 1 ; Transforming growth factor-b1 ; Tumor necrosis factor-α ; unilateral ureteral obstruction ; Urea ; Vimentin ; Western blotting</subject><ispartof>Pharmaceutical biology, 2020-01, Vol.58 (1), p.828-837</ispartof><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2020</rights><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2020 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</citedby><cites>FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470153/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470153/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27479,27901,27902,53766,53768,59116,59117</link.rule.ids></links><search><creatorcontrib>Wang, Zhaohui</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Li, Bingsheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Du, Yongchao</creatorcontrib><creatorcontrib>Liu, Yuhang</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><creatorcontrib>Chen, Xiang</creatorcontrib><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><title>Pharmaceutical biology</title><description>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation. In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells. Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>Actin</subject><subject>AKT protein</subject><subject>Colorimetry</subject><subject>Creatinine</subject><subject>Curcumin</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Fibrosis</subject><subject>Immunohistochemistry</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Lipopolysaccharides</subject><subject>Mesenchyme</subject><subject>Nephropathy</subject><subject>NF-κB protein</subject><subject>Renal function</subject><subject>Signal transduction</subject><subject>Smooth muscle</subject><subject>TLR4 protein</subject><subject>Toll-like receptors</subject><subject>transforming growth factor beta 1</subject><subject>Transforming growth factor-b1</subject><subject>Tumor necrosis factor-α</subject><subject>unilateral ureteral obstruction</subject><subject>Urea</subject><subject>Vimentin</subject><subject>Western blotting</subject><issn>1388-0209</issn><issn>1744-5116</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAUhSMEomXgEZAssWGT1o6dvw2iHVEYdQQIlbVlx9cTjxI72E6rvBpLnoBHwsMUpLJg499zPl_5nix7SfAZwQ0-J7RpcIHbsyKNZ6TBLauKR9kpqRnLS0Kqx2mdNPlBdJI9C2GPMS4pLZ9mJ7RoqgqX7Wn2Yz37bh6NRSJGsLOIEJAHKwZkbAQfookmbbSR3gUTkNPIyRD93EVzC8jC1Hs3idgvSC4ozNPkIQRjdwgmE3sYkjsfIYDt-mVMpOiFDQnqLIrJOu_69FJv5PEo4ZMJ3Wy_sPOPV_nP75dIWIU-b-j1-cX1DQpml2obDvzDo3diCc-zJ1oMAV7cz6vs69W7m_WHfPvp_WZ9sc07VrIibxtBtSBEU0JZoXSpasIAU1WLThRE1g2VFSaN0sCwbMoKtNQVlqIsqroVDV1lmyNXObHnkzej8At3wvDfB87vuPDRdANw1dV1C1IVsgWmJJNaQdESpuq2ayk7sN4cWdMsR1Ad2PQtwwPowxtrer5zt7xmNSapi6vs9T3Au28zhMhHEzoYBmHBzYEXjLYVLWtSJOmrf6R7N_v0i0lVpthQeqyoPKq61OfgQf8thmB-SBz_kzh-SBy_T1zyvT36jNXOj-LO-UHxKJbBeZ1a3ZnA6f8RvwCCo-Hq</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Wang, Zhaohui</creator><creator>Chen, Zhi</creator><creator>Li, Bingsheng</creator><creator>Zhang, Bo</creator><creator>Du, Yongchao</creator><creator>Liu, Yuhang</creator><creator>He, Yao</creator><creator>Chen, Xiang</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Ltd</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200101</creationdate><title>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</title><author>Wang, Zhaohui ; Chen, Zhi ; Li, Bingsheng ; Zhang, Bo ; Du, Yongchao ; Liu, Yuhang ; He, Yao ; Chen, Xiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4542-98a3fa11f31342df5d714e03d7aca21b783b6018dfe40b856efbf60ba52679a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>Actin</topic><topic>AKT protein</topic><topic>Colorimetry</topic><topic>Creatinine</topic><topic>Curcumin</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Fibrosis</topic><topic>Immunohistochemistry</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Lipopolysaccharides</topic><topic>Mesenchyme</topic><topic>Nephropathy</topic><topic>NF-κB protein</topic><topic>Renal function</topic><topic>Signal transduction</topic><topic>Smooth muscle</topic><topic>TLR4 protein</topic><topic>Toll-like receptors</topic><topic>transforming growth factor beta 1</topic><topic>Transforming growth factor-b1</topic><topic>Tumor necrosis factor-α</topic><topic>unilateral ureteral obstruction</topic><topic>Urea</topic><topic>Vimentin</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zhaohui</creatorcontrib><creatorcontrib>Chen, Zhi</creatorcontrib><creatorcontrib>Li, Bingsheng</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Du, Yongchao</creatorcontrib><creatorcontrib>Liu, Yuhang</creatorcontrib><creatorcontrib>He, Yao</creatorcontrib><creatorcontrib>Chen, Xiang</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Pharmaceutical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zhaohui</au><au>Chen, Zhi</au><au>Li, Bingsheng</au><au>Zhang, Bo</au><au>Du, Yongchao</au><au>Liu, Yuhang</au><au>He, Yao</au><au>Chen, Xiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways</atitle><jtitle>Pharmaceutical biology</jtitle><date>2020-01-01</date><risdate>2020</risdate><volume>58</volume><issue>1</issue><spage>828</spage><epage>837</epage><pages>828-837</pages><issn>1388-0209</issn><eissn>1744-5116</eissn><abstract>Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects. To explore the mechanisms underlying the effects of curcumin on RIF. Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation. In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells. Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.</abstract><cop>Abingdon</cop><pub>Taylor &amp; Francis</pub><pmid>32866059</pmid><doi>10.1080/13880209.2020.1809462</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1388-0209
ispartof Pharmaceutical biology, 2020-01, Vol.58 (1), p.828-837
issn 1388-0209
1744-5116
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7470153
source Taylor & Francis Open Access; DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection
subjects 1-Phosphatidylinositol 3-kinase
Actin
AKT protein
Colorimetry
Creatinine
Curcumin
Enzyme-linked immunosorbent assay
Fibrosis
Immunohistochemistry
Inflammation
Interleukin 6
Lipopolysaccharides
Mesenchyme
Nephropathy
NF-κB protein
Renal function
Signal transduction
Smooth muscle
TLR4 protein
Toll-like receptors
transforming growth factor beta 1
Transforming growth factor-b1
Tumor necrosis factor-α
unilateral ureteral obstruction
Urea
Vimentin
Western blotting
title Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T07%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curcumin%20attenuates%20renal%20interstitial%20fibrosis%20of%20obstructive%20nephropathy%20by%20suppressing%20epithelial-mesenchymal%20transition%20through%20inhibition%20of%20the%20TLR4/NF-%D0%BAB%20and%20PI3K/AKT%20signalling%20pathways&rft.jtitle=Pharmaceutical%20biology&rft.au=Wang,%20Zhaohui&rft.date=2020-01-01&rft.volume=58&rft.issue=1&rft.spage=828&rft.epage=837&rft.pages=828-837&rft.issn=1388-0209&rft.eissn=1744-5116&rft_id=info:doi/10.1080/13880209.2020.1809462&rft_dat=%3Cproquest_pubme%3E2509433348%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2509433348&rft_id=info:pmid/32866059&rft_doaj_id=oai_doaj_org_article_dc779ebd2b9e4db4bfde2914d79c9348&rfr_iscdi=true